Olivier Danos, Chief Scientific Officer at REGENXBIO Inc. (RGNX), sold 32,284 shares at $63.73 ($2.1M) on 2018-10-08, disclosed to the SEC on 2018-10-10.
Open-market sale of $2.1M RGNX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.79 | 3,500 | $220K | 10.7% |
| 2 | $63.73 | 12,284 | $783K | 38.0% |
| 3 | $63.73 | 12,284 | $783K | 38.0% |
| 4 | $64.78 | 4,000 | $259K | 12.6% |
| 5 | $65.60 | 216 | $14K | 0.7% |
| Total | $63.77 avg | 32,284 |
| $2.1M |
| 100% |